16th March 2020
- 0 comments
LSP, the leading life sciences investor in Europe, has held its final close of LSP 6 at the $600 million hard cap. This is the largest fund ever raised in Europe focused on life sciences ventures. LSP currently has $1.1 billion of capital to invest across LSP 6, the LSP Health Economics Fund and LSP’s public fund and mandates.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.